title: [Use of etanercept in amyloidosis secondary to rheumatoid arthritis, a report of two cases].
abstract: Rheumatoid arthritis (RA) is one of the most common causes of AA amyloidosis. Most patients are asymptomatic and only when there are large deposits in certain organs, functional problems arise. We report two patients with amyloidosis secondary to RA, with renal and intestinal involvement, who responded to treatment with etanercept.
authors.affiliation: Sección de Reumatología, Hospital Universitario Puerta Del Mar, Cádiz, España. imaciasfdez@hotmail.com
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Macías Fernández
authors.forename: Antonia María
authors.initials: AM
authors.lastname: Fernández Rodríguez
authors.forename: Sergio
authors.initials: S
authors.lastname: García Pérez
mesh_terms: D000368:Aged; D000686:Amyloidosis / Q000175:diagnosis / Q000209:etiology*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D003108:Colonic Diseases / Q000175:diagnosis / Q000209:etiology*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000175:diagnosis / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept